Selected article for: "CPE cytopathic effect and cytopathic effect"
Author: Gwon, Yong-Dae; Strand, Mårten; Lindqvist, Richard; Nilsson, Emma; Saleeb, Michael; Elofsson, Mikael; Överby, Anna K.; Evander, Magnus
Title: Antiviral Activity of Benzavir-2 against Emerging Flaviviruses
  • Document date: 2020_3_22
    • ID: 0ym40eki_8
    Snippet: To propagate the p0 stock, confluent Vero B4 cells grown in 25T flasks (Sarstedt, Nümbrecht, Germany) were infected at 0.1 multiplicity of infection (MOI). The supernatants (p1 stocks) were collected when a cytopathic effect (CPE) and the ZsGreen signal were observed. The p1 stocks were titrated and used for the dose-response analysis and time of addition assay......
    Document: To propagate the p0 stock, confluent Vero B4 cells grown in 25T flasks (Sarstedt, Nümbrecht, Germany) were infected at 0.1 multiplicity of infection (MOI). The supernatants (p1 stocks) were collected when a cytopathic effect (CPE) and the ZsGreen signal were observed. The p1 stocks were titrated and used for the dose-response analysis and time of addition assay.

    Search related documents:
    Co phrase search for related documents
    • addition assay and cytopathic effect: 1, 2, 3, 4, 5, 6, 7
    • addition assay and dose response: 1
    • addition assay time and CPE cytopathic effect: 1, 2, 3
    • addition assay time and cytopathic effect: 1, 2, 3, 4, 5
    • addition assay time and dose response: 1
    • CPE cytopathic effect and cytopathic effect: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23, 24, 25
    • CPE cytopathic effect and dose response: 1, 2, 3
    • CPE cytopathic effect and dose response analysis: 1
    • CPE cytopathic effect and infection multiplicity: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10
    • CPE cytopathic effect and MOI infection multiplicity: 1, 2, 3, 4, 5
    • CPE cytopathic effect and p0 stock: 1
    • cytopathic effect and dose response: 1, 2, 3, 4
    • cytopathic effect and dose response analysis: 1
    • cytopathic effect and infection multiplicity: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20
    • cytopathic effect and MOI infection multiplicity: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11
    • cytopathic effect and p0 stock: 1
    • dose response and infection multiplicity: 1
    • infection multiplicity and MOI infection multiplicity: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23, 24, 25
    • infection multiplicity and MOI infection multiplicity infect: 1, 2, 3, 4